% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/biomarker_example_data.R
\docType{data}
\name{biomarker_examples}
\alias{biomarker_examples}
\alias{her2_breast_cancer_data}
\alias{pdl1_immunotherapy_data}
\alias{cyp2d6_pharmacogenomics_data}
\alias{oncotype_dx_data}
\alias{psa_longitudinal_data}
\title{Example Datasets for Biomarker Response Association Analysis}
\format{
Data frames with various structures for different biomarker analysis scenarios

An object of class \code{data.frame} with 500 rows and 13 columns.

An object of class \code{data.frame} with 400 rows and 14 columns.

An object of class \code{data.frame} with 300 rows and 17 columns.

An object of class \code{data.frame} with 250 rows and 34 columns.

An object of class \code{data.frame} with 800 rows and 13 columns.
}
\usage{
her2_breast_cancer_data

pdl1_immunotherapy_data

cyp2d6_pharmacogenomics_data

oncotype_dx_data

psa_longitudinal_data
}
\description{
These datasets provide realistic examples for demonstrating biomarker-response relationships
across different clinical scenarios including precision oncology, pharmacogenomics, and clinical trials.

\code{her2_breast_cancer_data}: Simulates HER2 expression and trastuzumab response
in breast cancer patients, demonstrating predictive biomarker analysis for targeted therapy.

\code{pdl1_immunotherapy_data}: Simulates PD-L1 expression and immunotherapy response
across different cancer types, demonstrating biomarker validation across indications.

\code{cyp2d6_pharmacogenomics_data}: Simulates CYP2D6 genotype and drug metabolism
demonstrating pharmacogenomic biomarker analysis for personalized dosing.

\code{oncotype_dx_data}: Simulates multi-gene expression panel for breast cancer
recurrence prediction, demonstrating composite biomarker analysis.

\code{psa_longitudinal_data}: Simulates PSA monitoring in prostate cancer patients
demonstrating longitudinal biomarker analysis and treatment response monitoring.
}
\author{
ClinicoPath package team
}
\keyword{datasets}
